.jpg)
.png)
All
A recent succession of negative studies— including two randomized, placebocontrolled intervention trials1, 2 and a large genetic association analysis3—calls for a careful re-examination of the approach to HDL-directed therapies. In May 2011 the Atherothrombosis Intervention in Metabolic... more
Cardiology Position in Monterey, California Live and work in one of the most beautiful coastal locations you can find throughout the country. The practice is located 2 hours from San Francisco right on the Pacific Ocean. About the Practice: We are a well-established group of highly... more
JACKSONVILLE, Fla. – (January 6, 2021) -- The National Lipid Association (NLA) is proud to announce that it has achieved reaccreditation status from Joint Accreditation for Interprofessional Continuing Education for a new six-year term through November 2026. This recent reaccreditation enables the... more
The National Lipid Association is proud to announce the first-ever NLA Junior Faculty Research Award. The purpose of the award is to encourage scholarly advancement of Junior Faculty in the pursuit of a career related to hyperlipidemia and other lipid disorders in humans. The award will be... more
MEMBERS ONLY: Early bird registration has been extended to August 9 for the NLA’s Fall CLU scheduled for Sept. 20-22 in Baltimore, MD. This meeting will include sessions on genetic disorders, population testing and emerging therapies, challenging case presentations and diagnostic... more
On July 24, 2015, the United States Food and Drug Administration approved the clinical use of the PCSK9 inhibitor, alirocumab, as an adjunct to diet and maximally tolerated statin therapy for adults with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease who... more
It is well known that women are not protected from cardiovascular events but experience event rates at older ages equivalent to men after a 10-year lag time. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study showed similar findings regarding atherosclerosis, with 25- to 34-... more
The inaugural Donald Fredrickson Conference on Familial Lipoprotein Disorders was convened on Sunday, April 29, 2018 at the end of the National Lipid Association Annual Scientific Sessions in Las Vegas. The meeting was chaired by Dr. Virgil Brown. Dr. Donald Fredrickson was an esteemed lipid... more
Dr. Google, referencing ACC, tells us that cardiometabolic disorders represent a cluster of interrelated risk factors, primarily hypertension, elevated fasting blood sugar, dyslipidemia, abdominal obesity, and elevated triglycerides. Examples of the disease include heart attack, stroke, diabetes... more